Vertex Pharmaceuticals Inc (VRTX)
400.76
-4.15
(-1.02%)
USD |
NASDAQ |
Apr 24, 16:00
400.73
-0.03
(-0.01%)
After-Hours: 20:00
Vertex Pharmaceuticals Total Long Term Debt (Quarterly): 0.00 for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 300.00M |
| September 30, 2016 | 297.75M |
| June 30, 2016 | 296.50M |
| March 31, 2016 | 295.82M |
| December 31, 2015 | 295.16M |
| September 30, 2015 | 294.83M |
| June 30, 2015 | 294.81M |
| March 31, 2015 | 294.79M |
| December 31, 2014 | 294.78M |
| September 30, 2014 | 294.74M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 400.00M |
| December 31, 2012 | 400.00M |
| September 30, 2012 | 400.00M |
| June 30, 2012 | 400.00M |
| March 31, 2012 | 400.00M |
| December 31, 2011 | 400.00M |
| September 30, 2011 | 498.42M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
--
Maximum
Jun 2019
--
Average
--
Median
Jun 2019
Total Long Term Debt (Quarterly) Benchmarks
| Amgen Inc | 64.61B |
| Eli Lilly and Co | 25.23B |
| Regeneron Pharmaceuticals Inc | 1.983B |
| Alpine Immune Sciences Inc | 0.00 |
| Moderna Inc | 0.00 |